• Info
  • Insider Ownership

Insider Trading & Ownership of Andrew Gengos

Location
Bothell, WA
Summary
The estimated net worth of Andrew Gengos is at least $4,167,438 dollars as of 16 Jan 2026. Andrew Gengos is the Chief Financial Officer of Terns Pharmaceuticals, Inc. and owns shares of Terns Pharmaceuticals, Inc. (TERN) stock worth about $4.11M. Andrew Gengos is the CFO and Chief Business Officer of Athira Pharma, Inc. and owns shares of LeonaBio, Inc. (LONA) stock worth about $55.2K.
Signature
/s/ David Strauss, as Attorney-in-Fact for Andrew Gengos
All Insider Reports
All Insider Reports

Follow Filing Activity

Follow Andrew Gengos and return when a new Insider Trading filing appears.

This tracks SEC filing changes for this page using existing product update flows.

Sponsored

Quick Takeaways

  • Andrew Gengos has 4 issuer positions tracked on this page.
  • Estimated disclosed ownership value: $4,167,438.
  • Recent insider filing activity is available below.

What Changed

  • Largest disclosed position: Terns Pharmaceuticals, Inc. ($4,112,235).
  • Past-year value change for that position: +$96,366.

Why This Matters

  • This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
  • You can cross-check role, issuer, and filing chronology directly against the SEC source.

Official SEC Source

Filed on Form 4

Insider ownership context is sourced from SEC Forms 3, 4, and 5.

See Original Filing

Ownership of Andrew Gengos

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
TERN Terns Pharmaceuticals, Inc. Chief Financial Officer $4,112,235 +$96,366 +2.4% 14 Jan 2026
LONA Athira Pharma, Inc. CFO and Chief Business Officer $55,203 03 Sep 2024
CYT Cyteir Therapeutics, Inc. Chief Business Officer 22 Feb 2022
TTRX Global Health Solutions, Inc Director 08 Oct 2025

Insider Transactions Reported by Andrew Gengos:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.